Vaping-related lung injury

Maxwell L. Smith; Michael B. Gotway; Laura E. Crotty Alexander; Lida P. Hariri

doi:10.1007/s00428-020-02943-0

Vaping-related lung injury

Maxwell L. Smith, Michael B. Gotway, Laura E. Crotty Alexander, Lida P. Hariri

Diagnostic Radiology

Research output: Contribution to journal › Review article › peer-review

Abstract

The use of electronic nicotine delivery systems has increased in popularity dramatically over the past decade. Although lung diseases caused by vaping have been reported since the modern invention of the electronic cigarette, in the summer of 2019, patients began to present to health care centers at epidemic levels with an acute respiratory illness relating to vaping, which the Center for Disease Control termed E-cigarette or vaping product use-associated lung injury (EVALI). This review discusses electronic nicotine delivery systems as well as the etiology, clinical presentation, imaging findings, pathologic features, treatment, and long-term consequences of EVALI. We conclude with the practical impact EVALI has had on the practice of pathology.

Original language	English (US)
Pages (from-to)	81-88
Number of pages	8
Journal	Virchows Archiv
Volume	478
Issue number	1
DOIs	https://doi.org/10.1007/s00428-020-02943-0
State	Published - Jan 2021

Keywords

E-cigarette or vaping product use-associated lung injury
Electronic nicotine delivery systems
Pathology
Vaping

ASJC Scopus subject areas

Pathology and Forensic Medicine
Molecular Biology
Cell Biology

Access to Document

10.1007/s00428-020-02943-0

Fingerprint Dive into the research topics of 'Vaping-related lung injury'. Together they form a unique fingerprint.

Cite this

@article{ef015375c21949cc8da12a590807a422,

title = "Vaping-related lung injury",

abstract = "The use of electronic nicotine delivery systems has increased in popularity dramatically over the past decade. Although lung diseases caused by vaping have been reported since the modern invention of the electronic cigarette, in the summer of 2019, patients began to present to health care centers at epidemic levels with an acute respiratory illness relating to vaping, which the Center for Disease Control termed E-cigarette or vaping product use-associated lung injury (EVALI). This review discusses electronic nicotine delivery systems as well as the etiology, clinical presentation, imaging findings, pathologic features, treatment, and long-term consequences of EVALI. We conclude with the practical impact EVALI has had on the practice of pathology.",

keywords = "E-cigarette or vaping product use-associated lung injury, Electronic nicotine delivery systems, Pathology, Vaping",

author = "Smith, {Maxwell L.} and Gotway, {Michael B.} and {Crotty Alexander}, {Laura E.} and Hariri, {Lida P.}",

note = "Publisher Copyright: {\textcopyright} 2020, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2021",

month = jan,

doi = "10.1007/s00428-020-02943-0",

language = "English (US)",

volume = "478",

pages = "81--88",

journal = "Virchows Archiv",

issn = "0945-6317",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Vaping-related lung injury

AU - Smith, Maxwell L.

AU - Gotway, Michael B.

AU - Crotty Alexander, Laura E.

AU - Hariri, Lida P.

PY - 2021/1

Y1 - 2021/1

N2 - The use of electronic nicotine delivery systems has increased in popularity dramatically over the past decade. Although lung diseases caused by vaping have been reported since the modern invention of the electronic cigarette, in the summer of 2019, patients began to present to health care centers at epidemic levels with an acute respiratory illness relating to vaping, which the Center for Disease Control termed E-cigarette or vaping product use-associated lung injury (EVALI). This review discusses electronic nicotine delivery systems as well as the etiology, clinical presentation, imaging findings, pathologic features, treatment, and long-term consequences of EVALI. We conclude with the practical impact EVALI has had on the practice of pathology.

AB - The use of electronic nicotine delivery systems has increased in popularity dramatically over the past decade. Although lung diseases caused by vaping have been reported since the modern invention of the electronic cigarette, in the summer of 2019, patients began to present to health care centers at epidemic levels with an acute respiratory illness relating to vaping, which the Center for Disease Control termed E-cigarette or vaping product use-associated lung injury (EVALI). This review discusses electronic nicotine delivery systems as well as the etiology, clinical presentation, imaging findings, pathologic features, treatment, and long-term consequences of EVALI. We conclude with the practical impact EVALI has had on the practice of pathology.

KW - E-cigarette or vaping product use-associated lung injury

KW - Electronic nicotine delivery systems

KW - Pathology

KW - Vaping

UR - http://www.scopus.com/inward/record.url?scp=85093927074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85093927074&partnerID=8YFLogxK

U2 - 10.1007/s00428-020-02943-0

DO - 10.1007/s00428-020-02943-0

M3 - Review article

C2 - 33106908

AN - SCOPUS:85093927074

VL - 478

SP - 81

EP - 88

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

IS - 1

ER -

Vaping-related lung injury

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this